HRP20170453T1 - Sinteza stirilpiridina radioaktivno obilježenih s 18f iz tosilatnih preteča i njihovi stabilni farmaceutski pripravci - Google Patents

Sinteza stirilpiridina radioaktivno obilježenih s 18f iz tosilatnih preteča i njihovi stabilni farmaceutski pripravci Download PDF

Info

Publication number
HRP20170453T1
HRP20170453T1 HRP20170453TT HRP20170453T HRP20170453T1 HR P20170453 T1 HRP20170453 T1 HR P20170453T1 HR P20170453T T HRP20170453T T HR P20170453TT HR P20170453 T HRP20170453 T HR P20170453T HR P20170453 T1 HRP20170453 T1 HR P20170453T1
Authority
HR
Croatia
Prior art keywords
ethoxy
pyridin
vol
vinyl
methyl
Prior art date
Application number
HRP20170453TT
Other languages
English (en)
Croatian (hr)
Inventor
Tyler Benedum
Geoff Golding
Nathaniel Lim
Wei Zhang
Original Assignee
Avid Radiopharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avid Radiopharmaceuticals, Inc. filed Critical Avid Radiopharmaceuticals, Inc.
Publication of HRP20170453T1 publication Critical patent/HRP20170453T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0069—Devices for implanting pellets, e.g. markers or solid medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HRP20170453TT 2008-12-31 2009-12-29 Sinteza stirilpiridina radioaktivno obilježenih s 18f iz tosilatnih preteča i njihovi stabilni farmaceutski pripravci HRP20170453T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14188508P 2008-12-31 2008-12-31
PCT/US2009/069741 WO2010078370A1 (en) 2008-12-31 2009-12-29 Synthesis of 18f-radiolabeled styrylpyridines from tosylate precursors and stable pharmaceutical compositions thereof
EP09837135.4A EP2381967B1 (en) 2008-12-31 2009-12-29 Synthesis of 18f-radiolabeled styrylpyridines from tosylate precursors and stable pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
HRP20170453T1 true HRP20170453T1 (hr) 2017-06-02

Family

ID=42310197

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20170453TT HRP20170453T1 (hr) 2008-12-31 2009-12-29 Sinteza stirilpiridina radioaktivno obilježenih s 18f iz tosilatnih preteča i njihovi stabilni farmaceutski pripravci

Country Status (35)

Country Link
US (1) US20100172836A1 (enExample)
EP (1) EP2381967B1 (enExample)
JP (1) JP5717650B2 (enExample)
KR (1) KR20110119670A (enExample)
CN (1) CN102271716B (enExample)
AU (1) AU2009335049B2 (enExample)
BR (1) BRPI0923890A2 (enExample)
CA (1) CA2748705C (enExample)
CO (1) CO6341578A2 (enExample)
CR (1) CR20110410A (enExample)
CY (1) CY1118658T1 (enExample)
DK (1) DK2381967T3 (enExample)
DO (1) DOP2011000210A (enExample)
EA (1) EA023014B1 (enExample)
EC (1) ECSP11011242A (enExample)
ES (1) ES2620402T3 (enExample)
HN (1) HN2011001810A (enExample)
HR (1) HRP20170453T1 (enExample)
HU (1) HUE033649T2 (enExample)
IL (1) IL213674A (enExample)
LT (1) LT2381967T (enExample)
MA (1) MA33004B1 (enExample)
MX (1) MX2011007063A (enExample)
MY (1) MY162312A (enExample)
NZ (1) NZ593848A (enExample)
PE (1) PE20120007A1 (enExample)
PL (1) PL2381967T3 (enExample)
PT (1) PT2381967T (enExample)
RS (1) RS55674B1 (enExample)
SG (1) SG172439A1 (enExample)
SI (1) SI2381967T1 (enExample)
TN (1) TN2011000318A1 (enExample)
UA (1) UA105914C2 (enExample)
WO (1) WO2010078370A1 (enExample)
ZA (1) ZA201104824B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010039815A1 (en) * 2008-09-30 2010-04-08 Case Western Reserve University Molecular probes for imaging of myelin
BR112012030946A2 (pt) * 2010-06-04 2016-11-01 Piramal Imaging Sa método para a produção de ligante para amiloide beta marcado com f-18
CA2801530C (en) 2010-06-04 2017-09-12 Piramal Imaging Sa Method for production of f-18 labeled amyloid beta ligands
TWI504414B (zh) * 2010-06-04 2015-10-21 Bayer Schering Pharma Ag 生產F-18標記之Aβ配位體之方法
WO2012145169A2 (en) * 2011-04-21 2012-10-26 The Regents Of The University Of California Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles
MY183997A (en) * 2011-06-21 2021-03-17 Life Molecular Imaging Sa Formulations of fluorinated stilbene suitable for pet imaging
CA2852840A1 (en) 2011-10-19 2013-04-25 Piramal Imaging Sa Improved method for production of f-18 labeled a.beta. ligands
CN102432529B (zh) * 2011-11-14 2014-03-26 江苏省原子医学研究所 一种苯乙烯基吡啶二硫二氮衍生物的制备方法
WO2013090497A1 (en) * 2011-12-15 2013-06-20 Ge Healthcare Limited Heterocyclic compounds as imaging probes of tau pathology
CN102526765B (zh) * 2011-12-31 2014-07-30 郑州泰基鸿诺药物科技有限公司 一种Aβ斑块显像剂及其制备方法
CN103965105A (zh) * 2013-01-29 2014-08-06 中山大学 苯乙烯基喹啉衍生物及其在治疗阿尔茨海默病症中的应用
CN103645254B (zh) * 2013-11-28 2015-01-07 江苏省原子医学研究所 一种Aβ斑块显像剂前体AV45的含量分析方法
WO2017014599A1 (ko) * 2015-07-22 2017-01-26 주식회사 씨코헬스케어 [18f]플루오로-도파의 방사화학적 순도를 안정화시키는 조성물 및 이의 제조방법
ES2864825T3 (es) * 2015-11-13 2021-10-14 Lilly Co Eli Derivados de azetidina para la obtención de imágenes Tau
EP3426309B1 (en) * 2016-03-09 2022-05-04 Case Western Reserve University Radioligands for myelin
CN107198780A (zh) * 2016-03-18 2017-09-26 南京江原安迪科正电子研究发展有限公司 放射性药物组合物及其制备方法、应用
CN106018575B (zh) * 2016-05-05 2018-10-19 江苏省原子医学研究所 一种PET显像剂前体TsOP-(+)-DTBZ及其光学异构体的分离测定方法
US10695450B2 (en) * 2016-07-26 2020-06-30 Laboratoires Cyclopharma Synthesis of a radioactive agent composition
DK3538161T3 (da) * 2016-11-08 2022-09-05 Univ California Fremgangsmåder til flerdosissyntese af [F-18]FDDNP til kliniske indstillinger
TW201906818A (zh) * 2017-05-31 2019-02-16 美商511製藥公司 新穎氘取代之正子發射斷層掃描(pet)顯影劑及其藥理應用
EA202091766A1 (ru) * 2018-01-24 2021-02-18 Ац Иммуне Са Композиции для диагностики для пэт-визуализации, способ получения композиции для диагностики и ее применение в диагностике
CN111499570B (zh) * 2019-01-31 2023-05-16 中国医学科学院放射医学研究所 一种av-45中间体的合成方法
CN111499544B (zh) * 2019-01-31 2022-12-02 中国医学科学院放射医学研究所 一种一锅法制备N-Boc-N-甲基-4-氨基苯乙烯的合成方法
JP7576334B2 (ja) * 2019-03-29 2024-10-31 国立研究開発法人量子科学技術研究開発機構 放射性医薬の製造方法及び放射性医薬
CN115400232A (zh) * 2021-05-26 2022-11-29 汉中汉核医疗科技有限公司 一种放射性药物合成方法
CN115403434A (zh) * 2021-05-26 2022-11-29 汉中汉核医疗科技有限公司 一种放射性药物的合成方法
CN113582885B (zh) * 2021-08-30 2023-04-21 南京克米斯璀新能源科技有限公司 一种烷基磺酸钠的生产方法
CN114805190A (zh) * 2022-06-08 2022-07-29 吉林大学第一医院 一种甲基苯胺类Aβ蛋白显像剂的双柱合成方法
KR20250107902A (ko) * 2022-11-14 2025-07-14 일라이 릴리 앤드 캄파니 플로르베타피르 전구체 av-105의 다형체 형태
CN119080714A (zh) * 2024-09-12 2024-12-06 四川大学 一种偶氮苯磺酸酯化合物及其制备方法和应用、放射性探针的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007525211A (ja) * 2004-01-19 2007-09-06 テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド パーキンソン病の診断検査
CA2591534C (en) * 2004-12-17 2013-08-06 The Trustees Of The University Of Pennsylvania Stilbene derivatives and their use for binding and imaging amyloid plaques
PL1999109T3 (pl) * 2006-03-30 2012-05-31 Univ Pennsylvania Pochodne styrylopirydyny i ich zastosowanie do wiązania i obrazowania blaszek amyloidowych

Also Published As

Publication number Publication date
MA33004B1 (fr) 2012-01-02
WO2010078370A1 (en) 2010-07-08
BRPI0923890A2 (pt) 2015-07-28
TN2011000318A1 (en) 2012-12-17
JP5717650B2 (ja) 2015-05-13
HK1162951A1 (en) 2012-09-07
HUE033649T2 (en) 2017-12-28
CN102271716A (zh) 2011-12-07
HN2011001810A (es) 2013-08-12
UA105914C2 (uk) 2014-07-10
SI2381967T1 (sl) 2017-03-31
EA023014B1 (ru) 2016-04-29
MX2011007063A (es) 2011-12-16
DK2381967T3 (en) 2017-03-27
ES2620402T3 (es) 2017-06-28
KR20110119670A (ko) 2011-11-02
US20100172836A1 (en) 2010-07-08
CN102271716B (zh) 2014-11-19
DOP2011000210A (es) 2011-09-15
CO6341578A2 (es) 2011-11-21
MY162312A (en) 2017-05-31
CR20110410A (es) 2011-12-08
CA2748705C (en) 2017-05-02
PL2381967T3 (pl) 2017-06-30
JP2012514007A (ja) 2012-06-21
SG172439A1 (en) 2011-07-28
IL213674A0 (en) 2011-07-31
CA2748705A1 (en) 2010-07-08
AU2009335049B2 (en) 2015-07-16
PE20120007A1 (es) 2012-01-16
ECSP11011242A (es) 2011-10-31
PT2381967T (pt) 2017-02-24
EP2381967B1 (en) 2017-01-18
EP2381967A1 (en) 2011-11-02
CY1118658T1 (el) 2017-07-12
IL213674A (en) 2016-04-21
EP2381967A4 (en) 2013-01-02
ZA201104824B (en) 2013-01-30
AU2009335049A1 (en) 2011-07-21
LT2381967T (lt) 2017-04-25
EA201170911A1 (ru) 2011-12-30
RS55674B1 (sr) 2017-06-30
NZ593848A (en) 2013-09-27

Similar Documents

Publication Publication Date Title
JP2012514007A5 (enExample)
JP6964450B2 (ja) 造影剤の合成および使用のための組成物、方法およびシステム
NZ593848A (en) Synthesis of 18f-radiolabeled styrylpyridines from tosylate precursors and stable pharmaceutical compositions thereof
ES2763960T3 (es) Derivados de piridina-3(2H)-ona en tanto que agentes de formación de imágenes para la detección de perfusión miocárdica
RU2485131C2 (ru) Производные пиридина, замещенные гетероциклическим кольцом и фосфоноксиметильной группой и содержащие их противогрибковые средства
JP2015537015A5 (enExample)
ES2634894T3 (es) Agentes de unión a PSMA y usos de los mismos
EP2744806B1 (en) Novel 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes
CN109200296A (zh) 用于合成显像剂和其中间体的方法和装置
AR076949A1 (es) Derivados de 1h-imidazo-(4,5-c)-quinolinona
TW200838852A (en) Styrylpyridine derivatives and their use for binding and imaging amyloid plaques
EP2501696A2 (en) Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
CA2617319A1 (en) Radiolabeled-pegylation of ligands for use as imaging agents
RU2014107486A (ru) Бициклические пиримидоновые соединения
US20170037008A1 (en) Phenyl benzyl ether derivative and preparation method and application thereof
Cai et al. Synthesis and structure− affinity relationships of new 4-(6-iodo-H-imidazo [1, 2-a] pyridin-2-yl)-N-dimethylbenzeneamine derivatives as ligands for human β-amyloid plaques
EP2489665B1 (en) Evaluation probe for central nervous system permeability, evaluation method for central nervous system permeability, and screening method using an evaluation probe for central nervous system permeability
JP2009538894A5 (enExample)
RU2009148821A (ru) Производные [1,10]фенантролина для лечения нейродегенеративных или гематологических заболеваний
JP2013506704A5 (enExample)
EP3216796B1 (en) Phosphonium compound and production method therefor
JP2019522673A5 (enExample)
Marchais-Oberwinkler et al. N-Oxide analogs of WAY-100635: new high affinity 5-HT1A receptor antagonists
RU2016128365A (ru) 5-арил-1-имино-1-оксо-[1,2,4]тиадиазины
US10434195B2 (en) Methylsulfonamide derivatives and uses related thereto